• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Nutraceuticals for Men: Muscle Health and Performance Nutrition

    Aging in Place: Healthy Lifestyles Supplement Science-Based Solutions

    Getting an Edge in Esports: Meeting the Health Needs of Competitive Gamers

    Beyond CBD: Cannabis Compounds Warrant Recognition and More Research

    Leveling Out the Energy Segment for Mainstream, and Rethinking Caffeine
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    FDA Issues Draft Guidance on NDI Enforcement Discretion

    GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board

    Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission

    Choline Alone May Improve Maternal DHA Status During Pregnancy

    Cranberry Consumption Linked to Memory and Neurological Function Improvements

    Bilberon Bilberry Extract Receives U.S. Patent For Eye Strain, Neck/Shoulder Pain
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Aiya America, Inc. (Aiya Matcha)

    PhytoGaia Inc

    Gencor

    Botanic Healthcare LLC

    Verdure Sciences
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Aiya America, Inc. (Aiya Matcha)

    PhytoGaia Inc

    Gencor

    Botanic Healthcare LLC

    Verdure Sciences
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs

    Multicomponent hemp extracts with trace levels of THC and other naturally occurring compounds have not been approved in any new drug.

    FDA Rejection of NDINs for Full Spectrum Hemp Extracts Fails to See Key Differences from Drugs
    Related CONTENT
    • FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    • Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    • AIDP’s Puremune Receives Authorization for Health Claim in Canada
    • Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022
    • Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient
    By Todd Harrison, Venable09.09.21
    By now, you may be aware that two pioneering companies, Irwin Naturals and Charlotte’s Web, answered the FDA bell and notified the agency of their intent to market full spectrum hemp extracts (FSHE) with low levels of cannabidiol (CBD). However, while the FDA permitted the filing of the notifications, as required by the law, the agency continued to assert that a product containing CBD is precluded from being marketed as a dietary supplement.

    FDA’s position strains credulity at best. Simply stated, FSHE is not excluded from the definition of a dietary supplement because of the following: 1) FSHE is not the same “article” that has been subject to substantial, publicly disclosed clinical investigations as a drug; and 2) FSHE has been marketed as a food and as a dietary supplement prior to any substantial clinical trials investigating cannabis-derived compounds, including CBD isolates. This column discusses whether FSHE is the same article as Epidiolex and/or Sativex.

    Making Sense of the Arguments
    FDA’s statements that the presence of CBD in FSHE excludes them from dietary ingredient status are without merit. FDA relies heavily on the cultivation and manufacturing process that assures the quality and quantity of CBD as evidence the product is equivalent to Epidiolex and Sativex. FDA arrives at this conclusion based upon the statutory definition of a “dietary supplement” under section 201(ff) of the Food, Drug, and Cosmetic Act (FDCA).

    Specifically, that statutory provision provides in relevant part that “an article” may not be marketed as a dietary supplement, if all of the following are true: 1) it has been authorized for investigation as a new drug; 2) substantial clinical investigations have been instituted on the article and their existence made public; and 3) it was not marketed as a food or dietary supplement prior to being authorized for investigation as a new drug. For purposes of this exclusion, FDA has interpreted “authorized for investigation as a new drug” to mean that an investigational new drug application (IND) has been submitted for the active ingredient or active moiety.  

    The key issue is whether FSHE is “an article” that has either been approved or investigated as a “drug.” I understand FDA’s position to be that all CBD is the same “article,” which would mean that substantial clinical investigations instituted and made public by GW Pharma several years ago preclude the use of CBD in a dietary supplement—absent evidence establishing that CBD was marketed in dietary supplements prior to GW Pharma’s public announcement of the clinical investigations. 

    A careful reading of the statute strongly indicates that FDA’s position is contrary to Congressional intent. Congress intended to strike a balance between maintaining the incentive to develop new drugs while allowing access to dietary supplements that may contain a constituent that is the active moiety in the drug, but would not be expected to have the same  pharmacological effect. This interpretation is consistent with the Tenth Circuit’s decision in Pharmanex v. Shalala—the seminal case interpreting this provision of section 201(ff) (Pharmanex, Inc. v. Shalala, 221 F.3d 1151 (10th Cir. 2000); 2001 U.S. Dist. LEXIS 4598 (D. Utah  Mar. 30, 2001) (district court opinion on remand)).

    The Pharmanex case involved a company that developed a proprietary manufacturing process capable of increasing the levels of lovastatin in red yeast rice above the naturally occurring trace levels. FDA took the position that the particular red yeast rice used in Pharmanex’s Cholestin product was precluded under section 201(ff) from being marketed as a dietary ingredient, because it was not present in the food supply prior to FDA’s approval of lovastatin as a drug.

    In upholding FDA’s interpretation of section 201(ff), the court noted that Cholestin was pharmacologically equivalent to the lowest-dose lovastatin product marketed by Merck.

    In order to fit this paradigm, FDA indicates that a mere 65 mg of CBD is functionally equivalent to Epidiolex, which based on any reasonable calculation requires a minimum of 700 mg of CBD to exert its effect.

    This is certainly not the same as the red yeast rice that was the subject of the Pharmanex case; Cholestin contained the same level of lovastatin as the FDA-approved drug. Indeed, the court’s decision was compelled by the fact that, from a pharmacological viewpoint, Pharmanex’s red yeast rice was indistinguishable from Merck’s lovastatin in identity of active ingredient, strength of active ingredient, and mode of action. This is simply not the case with regard to the FSHE ingredients that were the subject of the recent New Dietary Ingredient Notifications (NDINs).

    Unique Extracts
    Importantly, studies have shown that multi-component cannabis extracts have displayed differentiated dose-response curves when compared to CBD isolates. Cannabis contains hundreds of compounds and various preclinical studies have shown that different cannabinoids  display unique pharmacological and pharmacokinetic profiles.

    Furthermore, studies demonstrating the interplay between cannabinoids and other classes of compounds have established the fact that chemical synergy results in unique pharmacological effects. Pharmaceutical drugs consisting of one or two active cannabinoids, at specific standardized amounts, will have distinct mechanisms of action compared to full-spectrum extracts, and each other. FDA simply ignores this fact and does not even attempt to address it.

    Indeed, pharmaceutical drugs created from cannabis extracts are an example of how small changes in the ratios of the same cannabinoids can have major consequences in terms of  efficacy and pharmacology. For sure, the FSHE in the NDINs had unique chemical profiles when  compared to approved drugs. Moreover, the maximum proposed daily amount of CBD from intake of the FSHE differs from that present in Epidiolex. Having established that chemical profile differences translate to changes in pharmacological action, FDA’s position that any level of CBD excludes the ingredient from being eligible as a dietary supplement is misguided.

    The primary cannabinoids that define the chemistries of Epidiolex and Sativex are CBD and delta-9-tetrahydrocannabinol (THC), which are derived from the acidic precursors cannabidiolic acid (CBDA) and delta-9-tetrahydrocannabinolic acid (THCA).

    However, Cannabis sativa contains approximately 120 different cannabinoids, which have been described in peer-reviewed journal articles. Cannabinoids are unique to the Cannabis sativa plant and can be separated into two types, neutral cannabinoids and acidic cannabinoids, depending on whether they contain a carboxyl group.

    In live plants, cannabinoids are found in their acidic form. The decarboxylation reaction occurs through non-enzymatic processes, such as light exposure, heating, or aging. After the plant is harvested, each processing step—such as drying, milling, storage, extraction, and/or smoking—produces a little more of the neutral, decarboxylated cannabinoids.

    Fundamental Differences
    Simply stated, FSHE is fundamentally different from both Epidiolex and Sativex. Multicomponent hemp extract with trace levels of naturally occurring THC (< 0.3%) and other naturally occurring cannabinoids, terpenoids, flavonoids, and phytochemicals, has not been approved in any new drug. FSHE is further distinguished by:

    1. FSHE contains CBD and trace amounts of THC as a component of a more complex mixture that has not itself been approved as a drug.
    2. FSHE does not contain added CBD or THC.
    3. FSHE is being marketed for use at a dose level that would not expose consumers to the therapeutic levels of CBD or THC used in approved drugs.

    In the parlance of the Pharmanex opinion, the relationship between FSHE and Epidiolex and Sativex is a far cry from the nearly identical properties shared by Cholestin and prescription lovastatin products. FSHE exhibits differentiated pharmacological properties and is not the same “article” that is the subject of substantial clinical investigations or FDA approval for Dravet syndrome or Lennox-Gastaut syndrome—two rare forms of epilepsy. 

    To state it more concisely, FSHE and GW Pharma’s cannabis-derived drugs have nothing in common with each other. The NDIN exercise Irwin Naturals and Charlotte’s Web completed shows that FDA is unlikely to change its mind absent action by Congress to amend the law to make it clear that FSHE is not precluded under the FDCA.


    About the Author: Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com. 
    Related Searches
    • Quality & Safety
    • Herbs & Botanicals
    • Regulations
    Related Knowledge Center
    • Herbs & Botanicals
    • Regulations
    • Quality & Safety
    Suggested For You
    FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products
    Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal
    AIDP’s Puremune Receives Authorization for Health Claim in Canada AIDP’s Puremune Receives Authorization for Health Claim in Canada
    Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022 Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022
    Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient
    NAC Supplements Could be Banned Unless FDA Reverses Course NAC Supplements Could be Banned Unless FDA Reverses Course
    Michelle Martin Combines Passion & Purpose as President and COO of Cypress Systems Michelle Martin Combines Passion & Purpose as President and COO of Cypress Systems
    Bergamot Polyphenolic Fractions May Lower Cholesterol Profile Bergamot Polyphenolic Fractions May Lower Cholesterol Profile
    Amino Acid Decision in Europe May Represent Small Step Toward Harmonization Amino Acid Decision in Europe May Represent Small Step Toward Harmonization
    High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children High DHA, Low Linoleic Acid Medical Food Shown to Help Cognitive Recovery in Malnourished Children
    Noochy Crisp Receives Best Tasting Functional Food Award at Vitafoods Europe Noochy Crisp Receives Best Tasting Functional Food Award at Vitafoods Europe
    Foodarom Group Inc. Foodarom Group Inc.
    Dyna-Tabs, LLC Dyna-Tabs, LLC
    HP Ingredients HP Ingredients
    Synergized Ingredients Synergized Ingredients

    Related Content

    • Breaking News | Herbs & Botanicals | Industry & Market News | Quality & Safety | Regulations
      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      FDA Issues Warning Letters to Companies Selling CBD, Delta-8 THC Products

      This marked the first time the agency took enforcement action against a delta-8 THC-containing product.
      05.04.22

    • Dietary Supplements | Healthy Aging | Herbs & Botanicals | Medical Nutrition
      Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal

      Autophagy (the Body’s Garbage Disposal) Key to Cellular Renewal

      Researchers have been studying autophagy and its role in the development of chronic disease and the physical changes associated with aging.
      By Gregory Stephens, Windrose Partners, and Sheila Campbell, PhD, RD 04.14.22

    • Breaking News | Delivery & Dosage Technologies | Dietary Supplements | Immune Function | Probiotics & Prebiotics | Regulations | Supplier News | World Markets
      AIDP’s Puremune Receives Authorization for Health Claim in Canada

      AIDP’s Puremune Receives Authorization for Health Claim in Canada

      Its insoluble yeast beta-glucan can now be marketed for immune support at a dose of 30 mg.
      04.05.22


    • Breaking News | Cognitive Function | Dietary Supplements | Healthcare Trends | Industry & Market News | Mood Health & Sleep
      Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022

      Informa to Hold Day-Long Summit on Mental Wellbeing Ahead of Vitafoods Europe 2022

      There will be 15 speakers across 11 live sessions, two panel discussions, and other networking events the day before Vitafoods Europe begins.
      03.21.22

    • Breaking News | Cardiovascular Health | Herbs & Botanicals | Natural/Organic | Supplier News | World Markets
      Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient

      Pharmactive Biotech Launches Aged Black Garlic Gummy Ingredient

      The sweet, odor-free flavor of the extract makes it suitable for the top-trending delivery platform.
      03.16.22

      Trending
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk In Older Adults | Nutraceuticals World
      • Leaven Essential To Launch Branded Botanical Extracts To Global Markets | Nutraceuticals World
      • Indena’s Meriva Curcumin Supplement May Benefit Kidney Function
      • Vitamin D3, Omega-3s, Exercise May Cumulatively Reduce Cancer Risk in Older Adults
      • Test On Hydrolyzed Collagen Shows Resoundingly High Bioavailability | Nutraceuticals World
      Breaking News
      • GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      • Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      • Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      • Choline Alone May Improve Maternal DHA Status During Pregnancy
      • Cranberry Consumption Linked to Memory and Neurological Function Improvements
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Aging in Place: Lifestyle Supplements Science-Based Solutions
      • Getting an Edge in Esports: Meeting Health & Nutrition Needs
      • Nutraceuticals for Men: Muscle Health and Performance Nutrition

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Creates Infographic Highlighting Omega-3 Health Claims Approved in Europe
      Kyowa Hakko Appoints Dr. Colin Hill to Immuse Scientific Advisory Board
      Expert Consensus Statement: Diet is Best Primary Intervention to Achieve Diabetes Remission
      Coatings World

      Latest Breaking News From Coatings World

      Teknos Receives EcoVadis Gold Medal for Sustainability Performance
      AkzoNobel and Partners Team Up to Hack Carbon Reduction Challenges
      Five PPG Facilities in Ohio Recognized for Sustainability, Health, Safety Practices
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Iterative Scopes Expands its Senior Leadership Team
      Viz.ai Raises $100 Million in Series D Funding
      FDA Clears Arterys' AI Mapping and Quantification Tools
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Piramal Pharma Solutions New API Plant in Canada Now Online
      MG America Appoints Claudio Radossi as President
      Catalent Invests $175M to Expand Mfg. Capabilities at Winchester, KY
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Authentic Beauty Concept Launches Second-Generation ‘Refill Bar’
      HASK Beauty Enters Exclusive Partnership with Amazon
      Garance Doré Launches Made in France Skincare Line
      Happi

      Latest Breaking News From Happi

      SPF Setting Spray, Lip Contour and Knotless Braids Are Hot Trends: Spate
      Nutrafol Launches Collagen Infusion
      ÄZ Craft Luxury Haircare Products Support All Hairstyles
      Ink World

      Latest Breaking News From Ink World

      Nazdar Celebrates 100 Years with a New Look
      hubergroup Chemicals Exhibits at Paint India for First Time
      Award for Sustainability: Evonik Receives Platinum Rating Again
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Specialty announces move to new facility
      Mark Andy hosts dealer's open house in Warsaw
      Nazdar celebrates 100th anniversary with refreshed brand identity
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      3M to Expand in Nebraska
      Nicely Offers Nonwoven Slitters, Winders
      'Right' Hygiene Conference to be Held in June
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      FDA Clears Anika Therapeutics' X-Twist Knotless Fixation System
      Paragon 28 Rolls Out TenoTac 2.0 Hammertoe and Soft Tissue Repair
      Cionic Expands Scientific Advisory Board
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Evonik Launches New Processing Aids for PV Wafer Cutting
      NREL Creates Highest Efficiency 1-Sun Solar Cell
      eMagin Wins People’s Choice Award at Display Week 2022

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login